MCID: NRT001
MIFTS: 53

Neurotic Disorder

Categories: Mental diseases, Neuronal diseases

Aliases & Classifications for Neurotic Disorder

MalaCards integrated aliases for Neurotic Disorder:

Name: Neurotic Disorder 12 15 17
Adjustment Disorders 43 71 32
Neurosis 12 36 15
Reactive Depression 12 71
Neurotic Disorders 43 71
Neurotic Depression Reactive Type 12
Neurotic Depressive State 12
Depression, Neurotic 71
Depressive Neurosis 12
Neurotic Depression 12
Depressive Disorder 71
Psychoneurosis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4964
KEGG 36 H01671
SNOMED-CT 67 78667006 87414006
UMLS 71 C0001546 C0011579 C0011581 more

Summaries for Neurotic Disorder

KEGG : 36 Neurosis is a class of functional mental disorders involving distress but neither delusions nor hallucinations, whereby behavior is not outside socially acceptable norms. The state of research on neurosis has moved towards looking at biological and genetic substrates or mechanisms underlying neurosis. The recent literature shows acceptance of common mental disorders such as Generalized anxiety disorder (GAD), Panic disorder (PD), and Obsessive-compulsive disorder (OCD), across cultures replacing neurotic disorder. Usage of the diagnosis of neurosis has been decreased, and replaced by newer categories in the current popular classificatory systems. In the International Classification of Diseases (ICD-10), all disorders regarded as neurosis remained together but under the division of rubric 'neurotic, stress-related and somatoform disorders'. In the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), neurosis has been eliminated as a category.

MalaCards based summary : Neurotic Disorder, also known as adjustment disorders, is related to dissociative disorder and somatization disorder, and has symptoms including depressed reaction and depressed - symptom. An important gene associated with Neurotic Disorder is MFSD8 (Major Facilitator Superfamily Domain Containing 8), and among its related pathways/superpathways are Neuroactive ligand-receptor interaction and Dopaminergic synapse. The drugs Acetylcholine and Valsartan have been mentioned in the context of this disorder. Affiliated tissues include brain, testes and heart, and related phenotypes are behavior/neurological and nervous system

Disease Ontology : 12 An anxiety disorder that involves discress but neither delusions nor hallucinations.

Wikipedia : 74 Neurosis is a class of functional mental disorders involving chronic distress but neither delusions nor... more...

Related Diseases for Neurotic Disorder

Diseases related to Neurotic Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 293, show less)
# Related Disease Score Top Affiliating Genes
1 dissociative disorder 30.7 SLC6A4 HTR2A FLNA
2 somatization disorder 30.3 SLC6A4 HTR2A HTR1A
3 acute stress disorder 30.2 SLC6A4 MFSD8 BDNF
4 body dysmorphic disorder 30.1 SLC6A4 MAOA HTR2A
5 obsessive-compulsive personality disorder 30.1 SLC6A4 HTR2A
6 social phobia 30.1 SLC6A4 MAOA HTR1A
7 premenstrual tension 29.9 LIPN HTR1A
8 tic disorder 29.9 SLC6A4 MAOA HTR2A
9 hypochondriasis 29.9 SLC6A4 HTR2A HTR1A BDNF
10 eating disorder 29.8 SLC6A4 HTR2A BDNF
11 dysthymic disorder 29.8 SLC6A4 MAOA HTR2A HTR1A BDNF
12 panic disorder 29.8 SLC6A4 MAOA HTR2A HTR1A BDNF
13 adjustment disorder 29.8 SLC6A4 HTR2A FLNA BDNF
14 alexithymia 29.7 SLC6A4 IL6 HTR1A
15 delusional disorder 29.6 TH MFSD8 HTR2A HTR1A
16 alcohol use disorder 29.6 SLC6A4 HTR2A HTR1A BDNF
17 generalized anxiety disorder 29.6 SLC6A4 MAOA HTR2A HTR1A BDNF
18 agoraphobia 29.6 SLC6A4 MAOA HTR2A HTR1A
19 post-traumatic stress disorder 29.6 SLC6A4 MAOA HTR2A BDNF
20 antisocial personality disorder 29.4 SLC6A4 MAOA HTR2A
21 personality disorder 29.4 TH SLC6A4 MAOA HTR2A HTR1A BDNF
22 depression 29.4 SLC6A4 MAOA HTR2A HTR1A BDNF
23 melancholia 29.3 SLC6A4 MAOA HTR2A HTR1A BDNF
24 atypical depressive disorder 29.3 SLC6A4 MAOA HTR2A HTR1A BDNF
25 alcohol dependence 29.1 TH SLC6A4 MAOA HTR2A HTR1A BDNF
26 obsessive-compulsive disorder 29.0 SLC6A4 MAOA IL6 HTR2A HTR1A BDNF
27 dementia 28.8 TH MAOA HTR2A HTR1A BDNF
28 borderline personality disorder 28.8 TH SLC6A4 MAOA HTR2A HTR1A BDNF
29 narcolepsy 28.7 SLC6A4 MAOA IL6 HTR2A BDNF
30 major depressive disorder 28.6 SLC6A4 MAOA IL6 HTR2A HTR1A BDNF
31 paranoid schizophrenia 28.6 SLC6A4 MAOA IL6 HTR2A HTR1A BDNF
32 mental depression 28.6 SLC6A4 MAOA IL6 HTR2A HTR1A BDNF
33 psychotic disorder 28.5 TH SLC6A4 MAOA HTR2A HTR1A BDNF
34 substance abuse 28.4 SLC6A4 MAOA INS HTR2A HTR1A BDNF
35 schizoaffective disorder 28.4 SLC6A4 INS HTR2A HTR1A BDNF
36 autism 28.3 TH SLC6A4 MAOA HTR2A HTR1A BDNF
37 anorexia nervosa 28.2 SLC6A4 MAOA INS HTR2A HTR1A BDNF
38 fibromyalgia 28.1 SLC6A4 INS IL6 HTR2A BDNF
39 body mass index quantitative trait locus 11 28.1 MAOA INS IL6 HTR2A HTR1A BDNF
40 chronic fatigue syndrome 28.0 SLC6A4 MAOA INS IL6 HTR2A HTR1A
41 mood disorder 28.0 TH SLC6A4 MAOA IL6 HTR2A HTR1A
42 bipolar disorder 27.9 TH SLC6A4 MAOA IL6 HTR2A HTR1A
43 hypertension, essential 27.6 TH SLC6A4 INS IL6 HTR2A FLNA
44 sleep disorder 27.4 TH SLC6A4 INS IL6 HTR2A HTR1A
45 anxiety 27.4 TH SLC6A4 MAOA INS IL6 HTR2A
46 migraine with or without aura 1 27.3 SLC6A4 MAOA LIPN INS IL6 HTR2A
47 schizophrenia 27.3 TH SLC6A4 MAOA INS IL6 HTR2A
48 disease of mental health 27.0 TH SLC6A4 MAOA INS IL6 HTR2A
49 endogenous depression 27.0 TH SLC6A4 MAOA INS IL6 HTR2A
50 panic disorder 1 11.7
51 conversion disorder 11.6
52 orthostatic intolerance 11.5
53 wilson disease 11.2
54 combat disorder 11.2
55 parametritis 10.4 LY96 LY86
56 paranoid personality disorder 10.4 MFSD8 FLNA
57 intestinal botulism 10.4 LY96 FBXW2
58 interstitial emphysema 10.4 LY96 LY86
59 schizophrenia 5 10.4 HTR2A HTR1A
60 giant axonal neuropathy 2 10.4 GAN DCAF8
61 wound botulism 10.4 LY96 FBXW2
62 hypoactive sexual desire disorder 10.3 HTR2A HTR1A
63 internal hordeolum 10.3 LY96 LY86 FBXW2
64 avoidant personality disorder 10.3
65 head injury 10.3
66 inhibited male orgasm 10.3 SLC6A4 HTR1A
67 alcoholic psychosis 10.3 SLC6A4 HTR2A
68 drug psychosis 10.2 HTR2A HTR1A
69 psychosexual disorder 10.2 SLC6A4 HTR2A HTR1A
70 drug-induced mental disorder 10.2 HTR2A HTR1A
71 scalp dermatosis 10.2 SNRPD1 LY96 LY86 FBXW2
72 hyperthyroidism 10.2
73 bruxism 10.2 SLC6A4 HTR2A HTR1A
74 keloid formation 10.2 IL6 FLNA
75 pedophilia 10.2 MFSD8 MAOA
76 duodenal ulcer 10.2
77 depersonalization disorder 10.1
78 retrograde amnesia 10.1 SLC6A4 HTR1A BDNF
79 asthma 10.1
80 diabetes mellitus 10.1
81 diabetes insipidus 10.1
82 substance-induced psychosis 10.1 HTR2A HTR1A
83 kleptomania 10.1 SLC6A4 MAOA HTR1A
84 neonatal hypoxic and ischemic brain injury 10.1 TH BDNF
85 phobia, specific 10.1 SLC6A4 MAOA HTR1A
86 spinal arachnoiditis 10.1
87 body mass index quantitative trait locus 9 10.1
88 body mass index quantitative trait locus 8 10.1
89 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 10.1
90 body mass index quantitative trait locus 4 10.1
91 body mass index quantitative trait locus 10 10.1
92 body mass index quantitative trait locus 7 10.1
93 body mass index quantitative trait locus 12 10.1
94 body mass index quantitative trait locus 14 10.1
95 body mass index quantitative trait locus 18 10.1
96 body mass index quantitative trait locus 19 10.1
97 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.1
98 body mass index quantitative trait locus 20 10.1
99 angina pectoris 10.1
100 amnestic disorder 10.1
101 arachnoiditis 10.1
102 epilepsy 10.1
103 peptic ulcer disease 10.1
104 hypoglycemia 10.1
105 47,xyy 10.1
106 migraine with aura 10.1 SLC6A4 HTR2A FLNA
107 intermittent explosive disorder 10.0 SLC6A4 MAOA HTR2A
108 alcoholic neuropathy 10.0 MAOA GAN
109 pathological gambling 10.0 SLC6A4 MAOA HTR2A
110 raynaud disease 10.0
111 yemenite deaf-blind hypopigmentation syndrome 10.0
112 suppression amblyopia 10.0
113 amblyopia 10.0
114 mastitis 10.0
115 diarrhea 10.0
116 pellagra 10.0
117 raynaud phenomenon 10.0
118 headache 10.0
119 somatoform disorder 10.0
120 autonomic dysfunction 10.0
121 mitral valve prolapse 1 10.0
122 graves disease 1 10.0
123 trichotillomania 10.0
124 rheumatic heart disease 10.0
125 oculogyric crisis 10.0
126 sexual sadism 10.0
127 heart disease 10.0
128 fetishism 10.0
129 gout 10.0
130 hypothyroidism 10.0
131 factitious disorder 10.0
132 pharyngitis 10.0
133 arteriosclerosis 10.0
134 biliary dyskinesia 10.0
135 bronchopulmonary dysplasia 10.0
136 fibromatosis 10.0
137 cerebral hypoxia 10.0
138 hypoxia 10.0
139 tremor 10.0
140 whiplash 10.0
141 macular dystrophy with central cone involvement 9.9
142 mitral valve stenosis 9.9
143 heroin dependence 9.9 SLC6A4 MAOA BDNF
144 vascular dementia 9.9
145 binswanger's disease 9.9
146 hypersomnia 9.9
147 persistent idiopathic facial pain 9.9
148 bipolar i disorder 9.9 SLC6A4 HTR2A HTR1A BDNF
149 severe combined immunodeficiency 9.9
150 serotonin syndrome 9.9 SLC6A4 MAOA HTR2A HTR1A
151 brunner syndrome 9.9 SLC6A4 MAOA HTR2A HTR1A
152 impulse control disorder 9.9 SLC6A4 MAOA HTR2A HTR1A
153 cocaine abuse 9.9 SLC6A4 IL6 BDNF
154 bilateral acute depigmentation of the iris 9.9
155 hair whorl 9.8
156 rheumatoid arthritis 9.8
157 triiodothyronine receptor auxiliary protein 9.8
158 dermatitis, atopic 9.8
159 major affective disorder 8 9.8
160 major affective disorder 9 9.8
161 stuttering 9.8
162 physical disorder 9.8
163 rheumatic fever 9.8
164 impotence 9.8
165 opiate dependence 9.8
166 dermatitis 9.8
167 arthropathy 9.8
168 pustulosis of palm and sole 9.8
169 dystonia 9.8
170 psoriasis 9.8
171 anisocoria 9.8
172 arteries, anomalies of 9.8
173 hepatocellular carcinoma 9.8
174 pilomatrixoma 9.8
175 hand skill, relative 9.8
176 neurofibromatosis, type iv, of riccardi 9.8
177 pheochromocytoma 9.8
178 torticollis 9.8
179 varicose veins 9.8
180 adrenoleukodystrophy 9.8
181 arts syndrome 9.8
182 paine syndrome 9.8
183 aging 9.8
184 helicobacter pylori infection 9.8
185 schizophrenia 3 9.8
186 stroke, ischemic 9.8
187 coronary heart disease 1 9.8
188 myocardial infarction 9.8
189 intraocular pressure quantitative trait locus 9.8
190 hyperprolactinemia 9.8
191 striatal degeneration, autosomal dominant 2 9.8
192 chorea, childhood-onset, with psychomotor retardation 9.8
193 hyperlipoproteinemia, type iii 9.8
194 hypophosphatemia 9.8
195 cervical dystonia 9.8
196 adrenal gland pheochromocytoma 9.8
197 aphasia 9.8
198 nosophobia 9.8
199 colitis 9.8
200 ileitis 9.8
201 crohn's colitis 9.8
202 spinal disease 9.8
203 gastric ulcer 9.8
204 sexual masochism 9.8
205 brucellosis 9.8
206 miliaria rubra 9.8
207 coronary artery anomaly 9.8
208 esophagitis 9.8
209 goiter 9.8
210 choreatic disease 9.8
211 conduct disorder 9.8
212 miliaria 9.8
213 facial neuralgia 9.8
214 peptic esophagitis 9.8
215 rheumatic disease 9.8
216 vascular disease 9.8
217 neuroma 9.8
218 enthesopathy 9.8
219 pulmonary tuberculosis 9.8
220 shwartzman phenomenon 9.8
221 thrombophlebitis 9.8
222 gastritis 9.8
223 systemic scleroderma 9.8
224 nominal aphasia 9.8
225 essential tremor 9.8
226 thyroid gland disease 9.8
227 pneumonia 9.8
228 paraplegia 9.8
229 cerebrovascular disease 9.8
230 gastrointestinal system disease 9.8
231 myocarditis 9.8
232 cyclothymic disorder 9.8
233 arthritis 9.8
234 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.8
235 ulcerative colitis 9.8
236 scarlet fever 9.8
237 subacute delirium 9.8
238 crohn's disease 9.8
239 pulmonary embolism 9.8
240 encephalitis 9.8
241 adrenomyeloneuropathy 9.8
242 koro 9.8
243 brain injury 9.8
244 fainting 9.8
245 cranial neuralgia 9.8
246 acute radiation syndrome 9.8
247 postpartum depression 9.8 SLC6A4 MAOA HTR1A BDNF
248 non-alcoholic steatohepatitis 9.7 INS IL6
249 central hypoventilation syndrome, congenital 9.7 TH SLC6A4 HTR1A BDNF
250 tobacco addiction 9.7 SLC6A4 MAOA HTR2A BDNF
251 metachromatic leukodystrophy 9.7 SLC6A4 INS HTR1A
252 traumatic brain injury 9.7 IL6 BDNF
253 constipation 9.7 TH SLC6A4 FLNA BDNF
254 generalized atherosclerosis 9.7 INS IL6
255 major affective disorder 1 9.7
256 femoral neuropathy 9.7
257 lung disease 9.7
258 neuropathy 9.7
259 muscular dystrophy 9.7
260 chronic pain 9.7
261 segawa syndrome, autosomal recessive 9.6 TH INS
262 central nervous system disease 9.6 SLC6A4 IL6 HTR2A BDNF
263 leukemia, acute myeloid 9.6
264 macular degeneration, age-related, 1 9.6
265 leukemia, acute lymphoblastic 9.6
266 withdrawal disorder 9.6
267 lymphocytic leukemia 9.6
268 acute myocardial infarction 9.6
269 spinal cord injury 9.6
270 cranial nerve disease 9.6 LIPN IL6 BDNF
271 sexual disorder 9.6 SLC6A4 INS HTR2A HTR1A
272 phobic disorder 9.6 SLC6A4 MAOA HTR2A HTR1A BDNF
273 apnea, obstructive sleep 9.6 INS IL6 HTR2A
274 substance dependence 9.5 SLC6A4 MAOA IL6 BDNF
275 irritable bowel syndrome 9.5 SLC6A4 IL6 HTR2A HTR1A BDNF
276 agnosia 9.5 LIPN IL6 HTR1A BDNF
277 toxic encephalopathy 9.5 TH SLC6A4 IL6 BDNF
278 exudative vitreoretinopathy 1 9.5 INS IL6 BDNF
279 leptin deficiency or dysfunction 9.4 INS IL6 BDNF
280 diabetic encephalopathy 9.3 INS BDNF
281 peripheral vascular disease 9.3 INS IL6 HTR2A
282 gilles de la tourette syndrome 9.2 TH SLC6A4 MAOA HTR2A HTR1A BDNF
283 pervasive developmental disorder 9.2 TH SLC6A4 MAOA HTR2A HTR1A BDNF
284 attention deficit-hyperactivity disorder 9.1 TH SLC6A4 MAOA HTR2A HTR1A BDNF
285 autonomic nervous system disease 9.1 TH INS IL6 BDNF
286 bulimia nervosa 9.1 SLC6A4 MAOA INS HTR2A BDNF
287 motor neuron disease 9.1 INS IL6 HTR2A HTR1A BDNF
288 parkinson disease, late-onset 9.1 TH SLC6A4 MAOA HTR2A HTR1A BDNF
289 peripheral nervous system disease 9.1 INS IL6 GAN DCAF8 BDNF
290 sleep apnea 9.1 SLC6A4 INS IL6 HTR2A BDNF
291 sudden infant death syndrome 8.8 TH SLC6A4 MAOA IL6 HTR2A HTR1A
292 specific developmental disorder 8.6 SLC6A4 MAOA INS IL6 HTR2A HTR1A
293 alzheimer disease 8.1 TH SLC6A4 MAOA INS IL6 HTR2A

Graphical network of the top 20 diseases related to Neurotic Disorder:



Diseases related to Neurotic Disorder

Symptoms & Phenotypes for Neurotic Disorder

UMLS symptoms related to Neurotic Disorder:


depressed reaction, depressed - symptom

MGI Mouse Phenotypes related to Neurotic Disorder:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.73 BDNF FLNA GAN GPX4 HTR1A HTR2A
2 nervous system MP:0003631 9.36 BDNF FLNA GAN GPX4 HTR1A IL6

Drugs & Therapeutics for Neurotic Disorder

Drugs for Neurotic Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 616, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetylcholine Approved, Investigational Phase 4 51-84-3 187
2
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
3
Ropinirole Approved, Investigational Phase 4 91374-20-8, 91374-21-9 5095 497540
4
Reboxetine Approved, Experimental Phase 4 71620-89-8, 98769-81-4 123628 65856
5
Cycloserine Approved Phase 4 68-41-7 401 6234
6
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
7
Parathyroid hormone Approved, Investigational Phase 4 9002-64-6
8
Brexpiprazole Approved, Investigational Phase 4 913611-97-9 11978813
9
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
10
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
11
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
12
Amitriptyline Approved Phase 4 50-48-6 2160
13
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
14
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
15
Propranolol Approved, Investigational Phase 4 525-66-6 4946
16
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
17
Desipramine Approved, Investigational Phase 4 50-47-5 2995
18
Methyltestosterone Approved Phase 4 58-18-4 6010
19
Testosterone undecanoate Approved, Investigational Phase 4 5949-44-0
20
Testosterone enanthate Approved Phase 4 315-37-7 9416
21
Moclobemide Approved, Investigational Phase 4 71320-77-9 4235
22
Curcumin Approved, Experimental, Investigational Phase 4 458-37-7 969516
23
Memantine Approved, Investigational Phase 4 19982-08-2 4054
24
Ziprasidone Approved Phase 4 146939-27-7 60854
25
Iloperidone Approved Phase 4 133454-47-4 71360
26
Terazosin Approved Phase 4 63590-64-7 5401
27
Prazosin Approved Phase 4 19216-56-9 4893
28
Zolpidem Approved Phase 4 82626-48-0 5732
29
Calcium carbonate Approved, Investigational Phase 4 471-34-1
30
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
31
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
32
Methohexital Approved Phase 4 151-83-7 9034
33
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
34
Methadone Approved Phase 4 76-99-3 4095
35
Ribavirin Approved Phase 4 36791-04-5 37542
36
Sodium citrate Approved, Investigational Phase 4 68-04-2
37
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741
38
Medroxyprogesterone acetate Approved, Investigational Phase 4 71-58-9
39
Topiramate Approved Phase 4 97240-79-4 5284627
40
Isocarboxazid Approved Phase 4 59-63-2 3759
41
Doxepin Approved, Investigational Phase 4 1668-19-5 667477 667468
42
Protriptyline Approved Phase 4 438-60-8 4976
43
Trimipramine Approved Phase 4 739-71-9 5584 4055
44
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
45
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
46
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
47
Donepezil Approved Phase 4 120014-06-4 3152
48
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
49
Milnacipran Approved, Investigational Phase 4 92623-85-3 65833
50
Levomilnacipran Approved, Investigational Phase 4 96847-54-0
51
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
52
Acetylcysteine Approved, Investigational Phase 4 616-91-1 12035
53
Buspirone Approved, Investigational Phase 4 36505-84-7 2477
54
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
55
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
56
Metyrapone Approved, Investigational Phase 4 54-36-4 4174
57
Levodopa Approved Phase 4 59-92-7 6047
58
Carbidopa Approved Phase 4 28860-95-9 34359
59
Suvorexant Approved, Investigational Phase 4 1030377-33-3
60
Infliximab Approved Phase 4 170277-31-3
61
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
62
Metformin Approved Phase 4 657-24-9 14219 4091
63
Resveratrol Approved, Experimental, Investigational Phase 4 501-36-0 445154
64
Remifentanil Approved Phase 4 132875-61-7 60815
65
Alendronate Approved Phase 4 121268-17-5, 66376-36-1 2088
66
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
67
Aripiprazole lauroxil Approved, Investigational Phase 4 1259305-29-7 49831411
68
Bazedoxifene Approved, Investigational Phase 4 198481-32-2
69
Simvastatin Approved Phase 4 79902-63-9 54454
70
Ondansetron Approved Phase 4 99614-02-5 4595
71
Losartan Approved Phase 4 114798-26-4 3961
72
Oxcarbazepine Approved Phase 4 28721-07-5 34312
73
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
74
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4 437-38-7 3345
75
Methamphetamine Approved, Illicit Phase 4 537-46-2 10836
76
Clozapine Approved Phase 4 5786-21-0 2818